BNP Paribas London Form 8.3 - Dechra Pharmaceuticals plc (8798Z)
16 January 2024 - 11:44PM
UK Regulatory
TIDMDPH
RNS Number : 8798Z
BNP Paribas London
16 January 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: BNP Paribas SA
(b) Owner or controller of interests
and short positions disclosed, if
different from 1(a):
The naming of nominee or vehicle
companies is insufficient. For a trust,
the trustee(s), settlor and beneficiaries
must be named.
----------------------------
(c) Name of offeror/offeree in relation Dechra Pharmaceuticals plc
to whose relevant securities this
form relates:
Use a separate form for each offeror/offeree
----------------------------
(d) If an exempt fund manager connected
with an offeror/offeree, state this
and specify identity of offeror/offeree:
----------------------------
(e) Date position held/dealing undertaken: 15/01/2024
For an opening position disclosure,
state the latest practicable date
prior to the disclosure
----------------------------
(f) In addition to the company in No:
1(c) above, is the discloser making
disclosures in respect of any other
party to the offer?
If it is a cash offer or possible
cash offer, state "N/A"
----------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose
in more than one class of relevant securities of the offeror
or offeree named in 1(c), copy table 2(a) or (b) (as appropriate)
for each additional class of relevant security.
(a) Interests and short positions in the relevant securities
of the offeror or offeree to which the disclosure relates
following the dealing (if any)
Class of relevant security: GB0009633180 (1p ordinary)
Interests Short Positions
Number % Number %
(1) Relevant securities
owned and/or controlled: 7,818,840 6.86 -5,885,027 -5.17
--------------------- -------- --------------------- --------
(2) Cash-settled derivatives: 444,059 .39 -1,366,801 -1.20
--------------------- -------- --------------------- --------
(3) Stock-settled derivatives
(including options) and
agreements to purchase/sell: 0 0
--------------------- -------- --------------------- --------
TOTAL: 8,262,899 7.25 -7,251,828 -6.37
--------------------- -------- --------------------- --------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or
sell relevant securities, should be given on a Supplemental
Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including
directors" and other employee options)
Class of relevant security
in relation to which subscription
right exists:
Details, including nature
of the rights concerned and
relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c),
copy table 3(a), (b), (c) or (d) (as appropriate) for each
additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should
be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
GB0009633180 Sale -9,045 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -27 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -13,834 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 68 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 150,000 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -259 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 3 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -92 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -185 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 21 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -885 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 9 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -219 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Sale -4,161 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 78 38.6600 GBP
--------------- --------------------- --------------------------
GB0009633180 Purchase 742 38.6600 GBP
--------------- --------------------- --------------------------
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description e.g. opening/closing references unit
security e.g. CFD a securities
long/short position
increasing/reducing
a
long/short position
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price e.g. date money
relevant e.g. call selling, securities per unit American paid/
security option varying to which European received
etc. option etc. per unit
relates
(ii) Exercise
Class of Product Exercising/ Number of Exercise price
relevant description exercised securities per unit
security e.g. call option against
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit
security e.g. subscription, (if
conversion applicable)
4. Other Information
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement
or understanding, formal or informal, relating to relevant securities
which may be an inducement to deal or refrain from dealing entered
into by the person making the disclosure and any party to the
offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be
included. If there are no such agreements, arrangements or understandings,
state "none"
None
(b) Indemnity and other dealing arrangements
Details of any agreement, arrangement or understanding, formal
or informal, between the person making the disclosure and any
other person relating to:
(i) the voting rights of any relevant securities under any
option; or
(ii) the voting rights or future acquisition or disposal of
any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings,
state "none"
None
(c) Attachments
Is a supplemental Form 8 (Open Positions) attached? No
Date of Disclosure: 16/01/2024
Contact Name Compliance Control Room
-----------------------------
Telephone Number: 0207 595 9695
-----------------------------
Public disclosures under Rule 8 of the Code must be made
to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation
in relation to the Code's disclosure requirements on +44
(0)20 7638 0129.
*If the discloser is a natural person, a telephone number
does not need to be included, provided contact information
has been provided to the Panel's Market Surveillance Unit.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RETLQLFFZFLZBBL
(END) Dow Jones Newswires
January 16, 2024 07:44 ET (12:44 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Dec 2023 to Dec 2024
